< %=imgalt%>
US Elections Calendar ~ Barak Obama ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / 2007 / April / April 15, 2007
Launching Generic Pharmaceutical Patent Academy - Understand and Respond to Patents

Top News

Praja Rajyam decides to approach court to vacate the stay on roadshows

Several more blasts strike Mumbais Trident and Taj hotels

Air New Zealand Airbus A320 maintenance flight crashes in Mediterranean sea off France

Beyonce checks into rehab to prepare for movie role

Rediff.com launches Web-in-mail service

Pak pacer Asifs doping hearing postponed after Mumbai attacks

Mechanism behind regulation of food intake identified

Eye divergence triples kids mental illness risk

Launching Generic Pharmaceutical Patent Academy - Understand and Respond to Patents

GenericsWeb is delighted to announce the inaugural Generic Pharmaceutical Patent Academy, to be held on the 8th-10th of May in London. This is an exciting opportunity for those in the generic pharmaceutical industry to improve their understanding and effectiveness in a rapidly evolving industry.

London, UK (PRWeb) April 15, 2007 -- GenericsWeb is delighted to announce the inaugural Generic Pharmaceutical Patent Academy, to be held on the 8th-10th of May in London. This is an exciting opportunity for those in the generic pharmaceutical industry to improve their understanding and effectiveness in a rapidly evolving industry.

The Generic Pharmaceutical Patent Academy is a direct response to requests from generic drug development personnel to better understand and respond to patents. At no time in the past has the influence of patents been more significant on the industry, creating confusion and uncertainty with frightening regularity.

The Generic Pharmaceutical Patent Academy recognises the fundamental need for personnel performing different functions to understand how pharmaceutical patenting affects the generic development process and to integrate it into the development process by devising appropriate strategies.

This two and a half day course will be limited to groups of 20 participants and will be delivered in a workshop style with frequent opportunities for discussion and exercises. Content will be enhanced by reference to numerous real-life examples. For users of Pipeline Patent Intelligence, a supplementary half day workshop is also available, enabling current users to get the most out of their investment.

The Generic Pharmaceutical Patent Academy will deliver relevant, vital and high quality information by leading industry experts - including patent attorneys, lawyers and other industry professionals - sure to greatly enhance workplace effectiveness and career progression.
For more information please visit www.genericsweb.com/patent_academy

About GenericsWeb

GenericsWeb Pipeline Patent Intelligence provides unrivalled patent knowledge required to navigate your generic drug development with confidence, all at the click of a button. Established in 1999, GenericsWeb has customers in over 30 countries including legal practices, government departments, consultants and generic manufacturers. For further information about GenericsWeb Pipeline Patent Intelligence or the Pharmaceutical Patent Academy, contact Jesse Tale at j.tale @ genericsweb.com tel. +61-2-98186111 or, for European and U.S. customers contact Sweta Lee at s.lee @ genericsweb.com tel. +44 870 879 0081.

The website www.genericsweb.com also hosts a web portal dedicated to serving the generic pharmaceutical industry. Resources found at GenericsWeb include regularly updated news and articles, careers, business intelligence, industry links and product development services. Receive our free monthly newsletter 'INNsight' by registering online.

Press Contact: Sweta Lee
Company Name: GenericsWeb
Email: Email Us Here: http://www.prweb.com/emailmember.php?prid=518773
Phone: +44 870 879 0081
Website: www.genericsweb.com/patent_academy

Press Release Source: EMediaWire


AndhraNews.net News for April 15, 2007

Other Press Releases for April 15, 2007